Home
About
Overview
Sharing Data
ORCID
Help
History (25)
A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia.
A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma.
Systemic therapy for advanced or recurrent endometrial carcinoma.
Morphometric analysis of amygdla and hippocampus shape in impulsively aggressive and healthy control subjects.
Hedgehog signaling is involved in the BMP9-induced osteogenic differentiation of mesenchymal stem cells.
See All 25 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Hedgehog signaling is involved in the BMP9-induced osteogenic differentiation of mesenchymal stem cells.
Hedgehog signaling is involved in the BMP9-induced osteogenic differentiation of mesenchymal stem cells. Int J Mol Med. 2015 Jun; 35(6):1641-50.
View in:
PubMed
subject areas
Animals
Cell Differentiation
Cell Line
Growth Differentiation Factor 2
Hedgehog Proteins
Mice
Osteogenesis
Signal Transduction
authors with profiles
Tong-Chuan He